Dr. Bezos Will See You Now: Amazon Is Developing a Cancer Vaccine
Tech giant Amazon is reportedly partnering with the Seattle-based Fred Hutchinson Cancer Center to develop a cancer vaccine and has already begun recruiting for clinical trials.
Business Insider reports that an internal team at Amazon is developing a cancer vaccine in partnership with the Seattle-based Fred Hutchinson Cancer Center. The project is reportedly already recruiting patients to participate in an FDA-approved clinical trial.
The clinical test is reportedly aiming to develop personalized vaccines for the treatment of breast cancer and the skin cancer known as melanoma. The vaccine would offer a personalized cancer treatment at an affordable price, becoming an alternative to chemotherapy if trials are successful.
A summary posted on Clinicaltrials.gov states that information on the project was first shared my Amazon and Fred Hutchinson in late October. The study start date was set for June 9, 2022, and the estimated completion date is November 1, 2023. The trial is currently in the early Phase 1 stage and is looking for 20 patients over the age of 18 to test a “US FDA-regulated Drug Product,” according to the summary page.- READ MORE
Responses